Evidence map›Paper›PMID 41455166›Full record

ArticleParkinsonism & related disorders2026

White matter hyperintensities in the deep cerebral venous territory differ between subcortical and cortical 4-repeat tauopathies.

Mu-Hui Fu, Ryota Satoh, Farwa Ali, Heather M Clark, Julie Stierwalt, Yehkyoung C Stephens, Hossam Youssef, Jerusha G Bhaskaran, Dennis W Dickson, Keith A Josephs and 1 more

Abstract read
In one paragraph

Article in Parkinsonism & related disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mu-Hui FuDepartment of Neurology, Mayo Clinic, Rochester, MN, 55905, USA; Department of Neurology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, 83301, Taiwan. Electronic address: fu.muhui@mayo.edu.
Ryota SatohDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Farwa AliDepartment of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.
Heather M ClarkDepartment of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.
Julie StierwaltDepartment of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.
Yehkyoung C StephensDepartment of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.
Hossam YoussefDepartment of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.
Jerusha G BhaskaranDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Keith A JosephsDepartment of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.
Jennifer L WhitwellDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.

Funding

Longitudinal multi-modality imaging in progressive apraxia of speech (Diversity Supplement)R01DC012519 · NIDCD · MAYO CLINIC ROCHESTER · PI Jennifer Louise Whitwell · 2013 to 2026
$7.2M
Longitudinal Multi-modal Imaging in Progressive Supranuclear Palsy SyndromesR01NS089757 · NINDS · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A, WHITWELL, JENNIFER LOUISE · 2015 to 2024
$5.6M
The neurobiology of two distinct types of progressive apraxia of speechR01DC014942 · NIDCD · MAYO CLINIC ROCHESTER · PI Keith A Josephs, Rene Lynn Utianski · 2017 to 2026
$4.9M
Neuroinflammation, white matter integrity, AD biomarkers and pathology in corticobasal syndromeR01AG087140 · NIA · MAYO CLINIC ROCHESTER · PI Keith A Josephs, Jennifer Louise Whitwell · 2025 to 2026
$1.6M
NIA NIH HHS R01 AG087140NIDCD NIH HHS R01 DC012519NIDCD NIH HHS R01 DC014942NINDS NIH HHS R01 NS089757
6 · The paper itself

Abstract

backgroundProgressive supranuclear palsy (PSP) syndromes and corticobasal syndrome (CBS) are atypical parkinsonian disorders resulting from 4-repeat (4R) tauopathies. They target a common network of brain regions, although relative involvement of cortical and subcortical regions differs. White matter hyperintensities (WMHs) are explicit in neurodegenerative disorders, however, little is known about their distribution in 4R-tauopathies.

objectivesTo evaluate the distribution of WMHs in the cortical and subcortical predominant 4R-tauopathies using venous territory-based and the derivative layer designed atlases.

methodsNinety-five participants with clinical variants of PSP or CBS were recruited by the Neurodegenerative Research Group, Mayo Clinic, and were classified as cortical (n = 64) or subcortical (n = 31) predominant. WMH volume was calculated for superficial, deep cerebral venous territory, and the periventricular (PV) region. Additionally, a layered atlas was created to assess WMH volume from the lateral ventricles (LV) to the brain surface. WMH volumes, clinical tests, and vascular-relevant histories were compared across groups and to 50 age-matched controls.

resultsCompared to the cortical group, the subcortical group had greater WMHs in the deep venous territory (p = 0.04). The major WMHs in the subcortical group distributed in layers 5-10 (12-30 mm from the LV) (p ≤ 0.01). The subcortical group had more histories of old strokes, chronic kidney disease, and headache.

conclusionsThe distribution of WMHs in the deep cerebral venous territory and the presumed watershed zone suggests that dysfunction of the venous system may play a role in the pathomechanism of 4R-tauopathies, particularly subcortical variants.

Indexed as

Cerebral CortexCerebral VeinsCorticobasal DegenerationSupranuclear Palsy, ProgressiveTauopathiesWhite MatterAgedAged, 80 and overFemaleHumansMagnetic Resonance ImagingMaleMiddle Aged4R-tauopathiesCerebral venous territoryCorticobasal syndromeProgressive supranuclear palsyWhite matter hyperintensities

Identifiers

PMID41455166
PMCPMC13267527

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.